TMS Co., Ltd.
JPX: 4891.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Takuro Wakabayashi
- Employees
- 14
- Headquarters
- Fuchu, Japan
- IPO year
- 2022
- Market cap
- ¥6.9B
- Website
- https://www.tms-japan.co.jp
Loading 4891…
Loading profile data…Frequently asked questions about 4891
What does TMS Co., Ltd. (4891.T) do?
TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has complet...
Where does 4891.T trade?
TMS Co., Ltd. (4891.T) trades on the Tokyo Stock Exchange.
What sector is 4891.T in?
TMS Co., Ltd. (4891.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TMS Co., Ltd.?
Takuro Wakabayashi is the chief executive officer of TMS Co., Ltd. (4891.T).
Where is TMS Co., Ltd. headquartered?
TMS Co., Ltd. is headquartered in Japan.
Does 4891.T pay a dividend?
TMS Co., Ltd. (4891.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4891.T go public?
TMS Co., Ltd. (4891.T) completed its initial public offering in 2022.